Proteomics Characterization of Clear Cell Renal Cell Carcinoma.
Jesús Miranda-PomaLucía Trilla-FuertesRocío López-VacasElena López-CamachoEugenia García-FernándezAna PertejoMaría I Lumbreras-HerreraAndrea Zapater-MorosMariana Díaz-AlmirónAntje DittmannJuan Ángel Fresno VaraEnrique EspinosaPilar González-PeramatoÁlvaro Pinto-MarínAngelo Gámez-PozoPublished in: Journal of clinical medicine (2023)
ccRCC tumors can be classified in two different proteomics subtypes. CC1 and CC2 present specific proteomics profiles, reflecting alterations of different molecular pathways in each subtype. The knowledge generated in this type of studies could help in the development of new drugs targeting subtype-specific deregulated pathways.